127 related articles for article (PubMed ID: 9101644)
1. In vitro effects of rt-PA on platelet function and clot strength.
D'Amico EA; Chamone DA; Bydlowski SP
Thromb Res; 1997 Mar; 85(6):519-22. PubMed ID: 9101644
[No Abstract] [Full Text] [Related]
2. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator promotes platelet disaggregation in plasma.
Loscalzo J; Vaughan DE
J Clin Invest; 1987 Jun; 79(6):1749-55. PubMed ID: 2438305
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator inhibits aggregation of platelets in vitro.
Mizuta T; Imai C
Life Sci; 1988; 43(12):955-63. PubMed ID: 3139948
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of plasma plasminogen and fibrinogen, serum fibrin degradation products and degree of ADP induced platelet aggregation in acute myocardial infarction (author's transl)].
Zhonghua Xin Xue Guan Bing Za Zhi; 1979; 7(1):49-52. PubMed ID: 550980
[No Abstract] [Full Text] [Related]
6. Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.
Gurbel PA; Bliden KP; Saucedo JF; Suarez TA; DiChiara J; Antonino MJ; Mahla E; Singla A; Herzog WR; Bassi AK; Hennebry TA; Gesheff TB; Tantry US
J Am Coll Cardiol; 2009 Feb; 53(8):648-57. PubMed ID: 19232896
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
Penny WF; Ware JA
Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
[TBL] [Abstract][Full Text] [Related]
8. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
Carr ME; Carr SL; Merten SR
Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
[TBL] [Abstract][Full Text] [Related]
9. "Plasminogen steal" and clot lysis.
Torr SR; Nachowiak DA; Fujii S; Sobel BE
J Am Coll Cardiol; 1992 Apr; 19(5):1085-90. PubMed ID: 1532403
[TBL] [Abstract][Full Text] [Related]
10. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
11. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
12. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
Boldt J; Mengistu A
J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation.
Paolini R; Casonato A; Boeri G; Luzzatto G; Girolami A; Sasahara AA; Cella G
J Med; 1993; 24(2-3):113-30. PubMed ID: 8409776
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology.
Soria J; Soria C; Borg JY; Mirshahi M; Piguet H; Tron P; Fessard C; Caen JP
Br J Haematol; 1985 Jul; 60(3):503-14. PubMed ID: 3893523
[TBL] [Abstract][Full Text] [Related]
15. The effect of somatostatin on coagulation and platelet function in man.
Mielke CH; Gerich JE; Lorenzi M; Tsalikian E; Rodvien R; Forsham PH
N Engl J Med; 1975 Sep; 293(10):480-3. PubMed ID: 1152862
[TBL] [Abstract][Full Text] [Related]
16. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.
Ostrowski SR; Bochsen L; Windeløv NA; Salado-Jimena JA; Reynaerts I; Goodrich RP; Johansson PI
Transfusion; 2011 Feb; 51(2):344-56. PubMed ID: 20723169
[TBL] [Abstract][Full Text] [Related]
18. Ticagrelor reversal:
Calmette L; Martin AC; Le Bonniec B; Zlotnik D; Gouin-Thibault I; Bachelot-Loza C; Gaussem P; Godier A
J Clin Pathol; 2017 Sep; 70(9):733-739. PubMed ID: 28159767
[TBL] [Abstract][Full Text] [Related]
19. [Effect of iodinated roentgen contrast media on coagulation, fibrinolysis and platelets].
Schulze B; Riester P; Blanke D; Fees K; Lehnard G
Arzneimittelforschung; 1977; 27(11):2128-33. PubMed ID: 580014
[No Abstract] [Full Text] [Related]
20. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
Mousa SA
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
